{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T19:41:39Z","timestamp":1772134899076,"version":"3.50.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2018,3,13]],"date-time":"2018-03-13T00:00:00Z","timestamp":1520899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1038\/s41416-018-0022-0","type":"journal-article","created":{"date-parts":[[2018,3,9]],"date-time":"2018-03-09T09:50:02Z","timestamp":1520589002000},"page":"1000-1004","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Pre-B acute lymphoblastic leukaemia recurrent fusion, EP300-ZNF384, is associated with a distinct gene expression"],"prefix":"10.1038","volume":"118","author":[{"given":"Barbara J.","family":"McClure","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan L.","family":"Heatley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chung H","family":"Kok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Sadras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiyuan","family":"An","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy P.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard B.","family":"Lock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosemary","family":"Sutton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah L","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,3,13]]},"reference":[{"key":"22_CR1","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1053\/j.seminhematol.2013.10.001","volume":"50","author":"CG Mullighan","year":"2013","unstructured":"Mullighan, C. G. Genomic characterization of childhood acute lymphoblastic leukemia. Semin. Hematol. 50, 314\u2013324 (2013).","journal-title":"Semin. Hematol."},{"key":"22_CR2","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1038\/leu.2014.142","volume":"28","author":"CH Pui","year":"2014","unstructured":"Pui, C. H. et al. A revised definition for cure of childhood acute lymphoblastic leukemia. Leukemia 28, 2336\u20132343 (2014).","journal-title":"Leukemia"},{"key":"22_CR3","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/ng.3535","volume":"48","author":"T Yasuda","year":"2016","unstructured":"Yasuda, T. et al. Recurrent DUX4 fusions in B cell acute lymphoblastic leukemia of adolescents and young adults. Nat. Genet. 48, 569\u2013574 (2016).","journal-title":"Nat. Genet."},{"key":"22_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11790","volume":"7","author":"H Lilljebjorn","year":"2016","unstructured":"Lilljebjorn, H. et al. Identification of ETV6-RUNX1-like and DUX4-rearranged subtypes in paediatric B-cell precursor acute lymphoblastic leukaemia. Nat. Commun. 7, 11790 (2016).","journal-title":"Nat. Commun."},{"key":"22_CR5","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1038\/leu.2015.111","volume":"29","author":"Y Gocho","year":"2015","unstructured":"Gocho, Y. et al., Tokyo Children\u2019s Cancer Study, G. A novel recurrent EP300-ZNF384 gene fusion in B-cell precursor acute lymphoblastic leukemia. Leukemia 29, 2445\u20132448 (2015).","journal-title":"Leukemia"},{"key":"22_CR6","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ebiom.2016.04.038","volume":"8","author":"YF Liu","year":"2016","unstructured":"Liu, Y. F. et al. Genomic profiling of adult and pediatric B-cell acute lymphoblastic leukemia. EbioMedicine 8, 173\u2013183 (2016).","journal-title":"EbioMedicine"},{"key":"22_CR7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ymgme.2016.06.013","volume":"119","author":"R Dutta","year":"2016","unstructured":"Dutta, R., Tiu, B. & Sakamoto, K. M. CBP\/p300 acetyltransferase activity in hematologic malignancies. Mol. Genet. Metab. 119, 37\u201343 (2016).","journal-title":"Mol. Genet. Metab."},{"key":"22_CR8","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1101\/gr.209163.116","volume":"27","author":"M Qian","year":"2017","unstructured":"Qian, M. et al. Whole transcriptome sequencing identified a distinct subtype of acute lymphoblastic leukemia with predominant genomic abnormalities of EP300 and CREBBP. Genome Res. 27, 185\u2013195 (2017).","journal-title":"Genome Res."},{"key":"22_CR9","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1002\/pbc.26116","volume":"63","author":"M Shago","year":"2016","unstructured":"Shago, M., Abla, O., Hitzler, J., Weitzman, S. & Abdelhaleem, M. Frequency and outcome of pediatric acute lymphoblastic leukemia with ZNF384 gene rearrangements including a novel translocation resulting in an ARID1B\/ZNF384 gene fusion. Pediatr. Blood Cancer 63, 1915\u20131921 (2016).","journal-title":"Pediatr. Blood Cancer"},{"key":"22_CR10","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1038\/sj.leu.2403842","volume":"19","author":"R Starza La","year":"2005","unstructured":"La Starza, R. et al. CIZ gene rearrangements in acute leukemia: report of a diagnostic FISH assay and clinical features of nine patients. Leukemia 19, 1696\u20131699 (2005).","journal-title":"Leukemia"},{"key":"22_CR11","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3324\/haematol.2016.151035","volume":"102","author":"S Hirabayashi","year":"2016","unstructured":"Hirabayashi, S. et al. ZNF384-related fusion genes consist of a subgroup with a characteristic immunophenotype in childhood B-cell precursor acute lymphoblastic leukemia. Haematologica 102, 118\u2013129 (2016).","journal-title":"Haematologica"},{"key":"22_CR12","doi-asserted-by":"publisher","first-page":"e409","DOI":"10.3324\/haematol.2016.162925","volume":"102","author":"SL Heatley","year":"2017","unstructured":"Heatley, S. L. et al. High prevalence of relapse in children with Philadelphia-like acute lymphoblastic leukemia despite risk-adapted treatment. Haematologica 102, e409\u2013e493 (2017).","journal-title":"Haematologica"},{"key":"22_CR13","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"22_CR14","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1200\/JCO.2016.69.0073","volume":"35","author":"KG Roberts","year":"2017","unstructured":"Roberts, K. G. et al. High frequency and poor outcome of Philadelphia chromosome-like acute lymphoblastic leukemia in adults. J. Clin. Oncol. 35, 394\u2013401 (2017).","journal-title":"J. Clin. Oncol."},{"key":"22_CR15","doi-asserted-by":"publisher","first-page":"33994","DOI":"10.1074\/jbc.M701847200","volume":"282","author":"PM Evans","year":"2007","unstructured":"Evans, P. M. et al. Kruppel-like factor 4 is acetylated by p300 and regulates gene transcription via modulation of histone acetylation. J. Biol. Chem. 282, 33994\u201334002 (2007).","journal-title":"J. Biol. Chem."},{"key":"22_CR16","doi-asserted-by":"publisher","first-page":"7386","DOI":"10.1073\/pnas.0401002101","volume":"101","author":"NG Iyer","year":"2004","unstructured":"Iyer, N. G. et al. p300 regulates p53-dependent apoptosis after DNA damage in colorectal cancer cells by modulation of PUMA\/p21 levels. Proc. Natl. Acad. Sci. USA 101, 7386\u20137391 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41416-018-0022-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41416-018-0022-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41416-018-0022-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T17:01:59Z","timestamp":1684602119000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-018-0022-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,13]]},"references-count":16,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["22"],"URL":"https:\/\/doi.org\/10.1038\/s41416-018-0022-0","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.732838489.793551068","asserted-by":"object"}]},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,13]]},"assertion":[{"value":"7 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.L.W. receives research support from Novartis and BMS, and Honoraria from BMS. T.P.H. and D.Y. receive research support from Novartis, Ariad and BMS, and Honoraria and Advisory role from Novartis. All the other authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}